Inhibition of the pro‐apoptotic, pro‐degradation and pro‐inflammatory effects of S100A9 on NP cells may be a therapeutic strategy to slow disc degeneration. This evidence concerns the gene S100A9 and intervertebral disk degenerative disorder.